Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Novartis employee pleads guilty in Poland bribe case

An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.

Poland’s anti-corruption bureau charged two women with bribery. Prosecutors said they gave a health fund official a tourist trip worth more than $1,000 in exchange for backing the sale of a particular drug, Reuters said.… Continue Reading

Job: QA Compliance Analyst, Novartis

Job Title: QA Compliance Analyst

Employer: Novartis Pharmaceuticals

Location: Fort Worth, Texas

Description

Preparation, assembly, critical review and submission for approval of Field Action Assessments, regulatory reporting to ensure agreed and statutory target dates .… Continue Reading

Job: Deputy Compliance Officer

Job Title:  Deputy Compliance Officer

Employer: Novartis Pharmaceuticals

Location: East Hanover, New Jersey

 

Description

The Deputy Compliance Officer (DCO) directly supports the VP, Ethics & Compliance (CCO/CCH) and leads assigned elements of oversight of the compliance program .… Continue Reading

Job: Director, Global Integrity & Compliance

Job Title: Director, Global Integrity & Compliance

Employer: Novartis Pharmaceuticals

Location: Fort Worth, Texas

Job Description
 
Supporting the U.S. Business Unit leaders (Surgical) in addressing strategic compliance priorities and coordinating policy establishment, training, communication, monitoring and enforcement activities  .… Continue Reading

Drug sellers ‘take vacations’ amid China anti-graft campaign

Pharmas have told their sales teams to halt all activity in China to avoid being caught in the nationwide “enforcement storm,” according to the Guangdong-based Yangcheng Evening News.

“It is rumored that police in plain clothes are patrolling in hospitals; drug sales representatives will be fined 500 yuan ($81) and regional sales managers 1000 yuan ($162) once being caught in hospitals,” an unidentified sales representative told the paper.Continue Reading

Pharma’s China crack up

The headlines from Tuesday’s ethiXbase Monitor, a daily email of global corruption and compliance news, tell the story.

Here are the first four items:

China: Glaxo Executive Says Changes in China to Cut Drug Prices
Published on Jul 24, 2013 03:00 am
GlaxoSmithKline Plc (GSK)’s head of emerging markets said after meeting with government officials in Beijing some employees may have broken China’s laws and pledged corporate changes that will deliver cheaper medicines.

Continue Reading

Docs collect billions for drug promos

ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.

A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading

The Novartis Speakers Bureau

Last week, Novartis agreed to pay a $185 million criminal fine for off-label marketing of the epilepsy drug Trileptal, and $237.5 million to resolve civil allegations over kickbacks paid to doctors to prescribe Trileptal and five other drugs.… Continue Reading